CERo Therapeutics Holdings's total assets for Q1 2026 were $2.21M, a decrease of -39.44% from the previous quarter. CERO total liabilities were $11.46M for the fiscal quarter, a 26.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.